Detalles de la búsqueda
1.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727538
2.
Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysis.
Prostate
; 79(3): 281-287, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370697
3.
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Can Urol Assoc J
; 18(4): E127-E137, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381937
4.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418825
5.
Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario.
Can Urol Assoc J
; 17(4): 85-91, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36486175
6.
BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer System.
Can Urol Assoc J
; 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882539
7.
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada.
Prostate Cancer Prostatic Dis
; 26(1): 74-79, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35197558
8.
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada.
Urol Oncol
; 40(5): 192.e1-192.e9, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216890
9.
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study.
BJUI Compass
; 3(5): 383-391, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950037
10.
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study.
Eur J Cancer
; 152: 215-222, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34130153
11.
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists.
Can Urol Assoc J
; 15(2): E90-E96, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853135
12.
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer.
JNCI Cancer Spectr
; 5(6)2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34926988
13.
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada.
Cancers (Basel)
; 13(11)2021 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34200349
14.
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
Can Urol Assoc J
; 15(10): 353-358, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125066
15.
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Can Urol Assoc J
; 14(4): E137-E149, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702544
16.
Therapeutic Implication of Genomic Landscape of Adult Metastatic Sarcoma.
JCO Precis Oncol
; 3: 1-25, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100702
17.
2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights.
Can Urol Assoc J
; 16(4): 125-131, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358413
18.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials.
J Thorac Oncol
; 10(11): 1523-31, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536194
19.
Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.
Lung Cancer
; 86(3): 344-9, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439436
20.
Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs.
J Gastrointest Oncol
; 5(4): 247-52, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25083296